.svg)
.svg)
Editorial:
Clinical decision-making beyond the threshold of classification in bleeding coagulation disorders
Original research articles:
Gene therapy with etranacogene dezaparvovec in haemophilia B: about the 1st patient infused in Spain
Avatrombopag: beyond efficacy: experience of a center
Prophylaxis in patients with moderate and mild haemophilia: experience from a single centre
Inhibitors in non-severe hemophilia A: a case report
Review articles:
Regarding plasma-derived von Willebrand factor concentrates: what about viral safety?
Reflections on the importance of factor VIII and Von Willebrand factor pharmacokinetics in the safety and efficacy of current Von Willebrand factor concentrates
Scientific letters:
Emicizumab in acquired hemophilia A: a case report
Endovascular intervention for intracranial aneurysm with dual anti platelet therapy in a patient with severe hemophilia A
